2010
DOI: 10.1016/j.ccr.2009.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Immobilized ruthenium complexes and aspects of their reactivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
86
0
9

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 65 publications
(98 citation statements)
references
References 139 publications
3
86
0
9
Order By: Relevance
“…It is important to note that ruthenium nitrosyl complexes have been extensively explored as nitric oxide donors and/or photoreleasers [12][13][14][15]. However, the mechanism of this process is very different, involving a photoredox reaction that oxidizes the Ru(II) complex to Ru(III) prior to the photorelease.…”
Section: Introductionmentioning
confidence: 99%
“…It is important to note that ruthenium nitrosyl complexes have been extensively explored as nitric oxide donors and/or photoreleasers [12][13][14][15]. However, the mechanism of this process is very different, involving a photoredox reaction that oxidizes the Ru(II) complex to Ru(III) prior to the photorelease.…”
Section: Introductionmentioning
confidence: 99%
“…Among the NO donors, ruthenium nitrosyl complexes are particularly attractive because they are stable, can be either water soluble or not, deliver NO at different rates upon activation by reduction at biologically accessible potentials and/or by light irradiation, in either solution or matrices. [14][15][16][17][18]34,[40][41][42][43][44][45][46][47][48][49] These properties can be tuned by the adequate choice of ligands. 14,18 It should be pointed out that interesting biological activities for several of these complexes have already been reported.…”
Section: Introductionmentioning
confidence: 99%
“…; mac = tetraazamacrocycle). 14,18,41,45 The tetraazamacrocyclic Ru II and Ru III complexes exhibit some unusual features compared to alicyclic analogues. 18 One of their fundamental properties is the size of the macrocyclic ring.…”
Section: Introductionmentioning
confidence: 99%
“…Together with other types of matrices (Tfouni et al, 2010;Seabra, Durán, 2010;Saraiva et al, 2011;Riccio, Schoenfisch, 2012), dendrimers have been used as NOreleasing carriers platforms (Taite, West, 2006;Stasko, Schoenfisch, 2006;Stasko, Fischer, Schoenfisch, 2008;Benini, McGarvey, Franco, 2008;Lu et al, 2011). One of the advantages of the NO-donors dendrimers over others NO carriers systems is their ability of storage high concentrations of nitric oxide per unit of drug carrier.…”
Section: Dendrimers As a Platform For No Transportmentioning
confidence: 99%
“…A reasonable volume of the current research have been focused on attaching NO releasing compounds to different platforms (Eroy-Reveles, Mascharak, 2010;Tfouni et al, 2010;Seabra, Durán, 2010;Riccio, Schoenfisch, 2012;Jen et al, 2012), as nanoparticles (Friedman et al, 2008;Seabra, Durán, 2010), silica gel (Zanichelli, Sernaglia, Franco, 2006;Doro, Rodrigues-Filho, Tfouni, 2007), xerogels and dendrimers (Stasko, Schoenfisch, 2006;Stasko, Fischer, Schoenfisch, 2008;Benini, McGarvey, Franco, 2008;Lu et al, 2011). These strategies aimed to improve NO-donors stability (Lu et al, 2011), promote a high payload of nitric oxide on a single platform (Stasko, Schoenfisch, 2006;Stasko, Fischer, Schoenfisch, 2008) and achieve specific targets (Taite, West, 2006).…”
Section: Introductionmentioning
confidence: 99%